Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Price weighting can skew an index toward higher-priced stocks. This explanation covers implications for interpretation and strategy.
26,532 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Prediction markets tied to the World Cup final surge to record volumes, with Spain favored over Argentina as betting ...
The Pentagon and Energy Department completed the first airlift of a microreactor, moving a 5-MW unit from California ...
Wix.com (WIX) 2025 earnings offer a window into how a diversified website builder navigates growth, margins, and mone...
Chase has cut credit-card limits for some customers with minimal usage, raising questions about credit-score impact a...
Hybrids now make up about 20% of U.S. vehicle sales in Q4 2025, signaling a major shift in consumer buying and the tr...
Ford surprised markets with an upward revision to its 2026 guidance after a solid first quarter. This article breaks ...
Ohio suspends new data-center tax breaks after costs surge to $1.5B, triggering a review and a heated debate over AI ...
When a global star hits the stage again, the show isn’t just about the music. It’s a masterclass in turning a moment ...
In a landmark move, australia’s richest person just disclosed a stake worth more than $1 billion in SpaceX as the pri...
Arm Holdings trades around $347 as investors weigh AI-driven demand and data-center opportunities. Analysts see a pat...
Cineverse is navigating the shifting streaming landscape as it reports 2026 earnings. This guide explains what the nu...